![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessRenal cell carcinoma: the population, real world, and cost-of-illness
The RCC treatment landscape has evolved dramatically over the past decade. The purpose of this study is to present a real-world data estimation of RCC’s cost-of-illness for this tumour’s clinical pathway.
-
Article
Open AccessMalignant Melanoma: Direct Costs by Clinical and Pathological Profile
A number of studies have examined the impact of tumor stage on direct health care costs of patients with melanoma. This study aimed to investigate the association between the direct costs for melanoma and the ...
-
Article
Open AccessDifference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported els...
-
Article
Open AccessUsefulness of a fast track list for anxious patients in a upper GI endoscopy
To determine whether patients with no alarm signs who ask the endoscopist to shorten their waiting time due to test result anxiety, represent a risk category for a major organic pathology.